American Century Companies’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
AC
VCM
American Century Companies's RIGL Position: Q1 2026 in Review
American Century Companies increased its Rigel Pharmaceuticals (RIGL) stake by 114% in Q1 2026, buying an estimated $9.74M and bringing the position to 544,431 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #1308.
American Century Companies first reported a position in RIGL in Q2 2015 and has held it in 12 quarters since. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- American Century Companies held 544,431 shares of Rigel Pharmaceuticals worth $14.7M as of Q1 2026.
- American Century Companies bought 289,939 Rigel Pharmaceuticals shares in Q1 2026, an estimated $9.74M.
- Rigel Pharmaceuticals made up 0.01% of American Century Companies's portfolio in Q1 2026, its #1308 holding.
- American Century Companies first reported a position in Rigel Pharmaceuticals in Q2 2015 and has held it in 12 quarters since.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.